Source: 4-traders

Transdermal Delivery Solutions: Transdermal Delivery Solutions : Announces Regulatory Approval of Clinical Trials Commencement of Testagen� Topical Testosterone HypoSpray�

(4-traders.com) Transdermal Delivery Solutions, a leader in the development of spray-on drug delivery systems, announced today they are entering the pivotal phase of clinical trials ...http://www.4-traders.com/news/Transdermal-Delivery-Solutions-Announces-Regulatory-Approval-of-Clinical-Trials-Commencement-of-Te--22193577/

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250